Salt intake during pregnancy alters offspring's myocardial structure
Carregando...
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
ALVES-RODRIGUES, E. N.
ROSA, K. T.
SOUZA, R. M.
Citação
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, v.23, n.5, p.481-486, 2013
Resumo
Background and Aim: To evaluate the effects of low or high salt intake during pregnancy on left ventricle of adult male offspring. Methods and results: Low-(LS, 0.15%), normal-(NS, 1.3%) or high-salt (HS, 8% NaCl) diet was given to Wistar rats during pregnancy. During lactation all dams received NS as well as the offspring after weaning. To evaluate cardiac response to salt overload, 50% of each offspring group was fed a high-salt (hs, 4% NaCl) diet from the 21st to the 36th week of age (LShs, NShs, HShs). The remaining 50% was maintained on NS (LSns, NSns and HSns). Echocardiography was done at 20 and 30 weeks of age. Mean blood pressure (MBP), histology and left ventricular angiotensin II content (AII) were analyzed at 36 weeks of age. Interventricular septum, left ventricular posterior wall and relative wall thickness increased from the 20th to the 30th week of age only in HShs, cardiomyocyte mean volume was higher in HShs compared to NShs, LShs and HSns. AII and left ventricular fibrosis were not different among groups. Conclusions: HS during pregnancy programs adult male offspring to a blood pressure and angiotensin II independent concentric left ventricular hypertrophy, with no fibrosis, in response to a chronic high-salt intake.
Palavras-chave
Salt, Fetal programming, Left ventricular, hypertrophy
Referências
- Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140
- Barauna Valério Garrone, 2007, Clin Med Res, V5, P114, DOI 10.3121/cmr.2007.707
- Battista MC, 2005, J PHYSIOL-LONDON, V565, P197, DOI 10.1013/jphysiol.2004.078139
- Battista MC, 2002, AM J PHYSIOL-ENDOC M, V283, pE124, DOI 10.1152/ajpendo.00004.2001
- De Silva DS, 2009, AM J PHYSIOL-HEART C, V296, pH1983, DOI 10.1152/ajpheart.00002.2009
- Ding Y, 2010, J HYPERTENS, V28, P1290, DOI 10.1097/HJH.0b013e328337da8f
- Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473
- FROHLICH ED, 1993, AM J PHYSIOL, V264, pR30
- HUNT RA, 1995, CARDIOVASC RES, V29, P834, DOI 10.1016/S0008-6363(96)88620-2
- Jackson AA, 2002, CLIN SCI, V103, P633
- LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
- Lewington S, 2002, LANCET, V360, P1903
- Lopes KL, 2008, LIFE SCI, V82, P728, DOI 10.1016/j.lfs.2008.01.003
- McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x
- Muiesan ML, 2004, HYPERTENSION, V43, P731, DOI 10.1161/01.HYP.0000121223.44837.de
- SADOSHIMA J, 1993, CIRC RES, V73, P413
- Strazzullo P, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4567
- Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9
- Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778
- Takeda Y, 2000, ENDOCRINOLOGY, V141, P1901, DOI 10.1210/en.141.5.1901
- Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861
- Yoshida Y, 2010, CIRC J, V74, P156, DOI 10.1253/circj.CJ-09-0050
- Yu HCM, 1998, CIRCULATION, V98, P2621
- YUAN BX, 1991, AM J PHYSIOL, V261, pH1397